Skip to main content
Equibles

Charles C. Duncan

Board Member

Vanda Pharmaceuticals Inc. (VNDA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Vanda Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.

Get VNDA alerts

About Charles C. Duncan

Charles C. Duncan is recorded as Board Member at Vanda Pharmaceuticals Inc. (VNDA) since January 1, 2026. The newest filing on record that lists Charles C. Duncan as Board Member at Vanda Pharmaceuticals Inc. (VNDA) is dated April 23, 2026. Vanda Pharmaceuticals Inc. reported in an 8-K filed April 22, 2026 that Charles C. Duncan was appointed director, effective April 22, 2026. Vanda Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vanda Pharmaceuticals Inc. includes Mihael Polymeropoulos (CEO and Board Member), Kevin Moran (CFO), Anne Sempowski Ward (Board Member) and 5 others.

“On April 22, 2026, the Board of Directors (the "Board") of Vanda Pharmaceuticals Inc. (the "Company") expanded the size of the Board from six to seven members, effective immediately and appointed Charles C. Duncan, Ph.D., as a director of the Company to fill the vacancy created by the expansion.”
Vanda Pharmaceuticals Inc. Form 8-K, filed April 22, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Vanda Pharmaceuticals Inc.

Recent activity